Insights into Cripto-1 as a target for cancer diagnosis and treatment: A mini-review
Advances in Radiotherapy & Nuclear Medicine · 2025
DOI: 10.36922/arnm025130015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Radiotherapy & Nuclear Medicine, 2025. Verfasst von Zhengkun Gao und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Cripto-1, a glycoprotein and key member of the epidermal growth factor-Cripto-1-FRL-1-Cryptic family, has garnered significant attention in cancer research due to its dual roles in embryonic development and tumor progression. The central role of Cripto-1 in regulating signaling pathways that govern cell behavior positions it as a promising target for enhancing diagnostic precision and therapeutic efficacy in cancer management. This mini-review explores the role of Cripto-1 in cancer biology, focusing on its involvement in key oncogenic pathways such as cell proliferation, migration, angiogenesis, and the maintenance of cancer stem cells (CSCs). Cripto-1 supports CSC self-renewal and contributes to treatment resistance. The review also examines recent advances in Cripto-1-targeted therapy, including monoclonal antibodies, small molecule inhibitors, and early-phase clinical trials, highlighting their therapeutic efficacy and safety profile. By synthesizing these findings, this review offers a comprehensive understanding of Cripto-1’s clinical relevance and provides new insights into its potential to improve diagnostic accuracy and therapeutic outcomes in cancer management.
Zitieren
APA
Gao, Z., Li, Q., Zheng, R., Si, J., Wang, B., & Gan, L. (2025). Insights into Cripto-1 as a target for cancer diagnosis and treatment: A mini-review. Advances in Radiotherapy & Nuclear Medicine. https://doi.org/10.36922/arnm025130015
Vancouver
Gao Z, Li Q, Zheng R, Si J, Wang B, Gan L. Insights into Cripto-1 as a target for cancer diagnosis and treatment: A mini-review. Advances in Radiotherapy & Nuclear Medicine. 2025. doi:10.36922/arnm025130015
BibTeX
@article{Gao2025,
author = {Gao, Zhengkun and Li, Qian and Zheng, Ran and Si, Jing and Wang, Bing and Gan, Lu},
title = {Insights into Cripto-1 as a target for cancer diagnosis and treatment: A mini-review},
journal = {Advances in Radiotherapy & Nuclear Medicine},
year = {2025},
doi = {10.36922/arnm025130015}
}
EUVIMED